DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ, Jitka ABRAHÁMOVÁ, Rostislav VYZULA and Jiří VORLÍČEK. A new concept for modelling the number of cancer patients potentially treated in the Czech Republic. In TIES 2007. 2007. ISBN 978-80-210-4333-6.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Name in Czech Modelování počtu potenciálně léčených onkologických pacientů v ČR
Name (in English) A new concept for modelling the number of cancer patients potentially treated in the Czech Republic
Authors DUŠEK, Ladislav, Tomáš PAVLÍK, Eva GELNAROVÁ, Jan MUŽÍK, Jana KOPTÍKOVÁ, Jitka ABRAHÁMOVÁ, Rostislav VYZULA and Jiří VORLÍČEK.
Edition TIES 2007, 2007.
Other information
Original language Czech
Type of outcome Presentations at conferences
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
ISBN 978-80-210-4333-6
Keywords in English modelling; cancer prevalence; cancer survival; cancer incidence
Tags cancer incidence, cancer prevalence, cancer survival, Modelling
Changed by Changed by: RNDr. Tomáš Pavlík, Ph.D., učo 52483. Changed: 30/6/2008 12:43.
Abstract
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.
Abstract (in English)
The approach combines epidemiological trends in incidence and prevalence with demographic databases (used for estimates of relative X-yrs survival) and with cancer-specific mortality data that were applied to estimate the rate of dissemination relapses of the disease. The functionality and power of the model is well documented on Czech National Cancer Registry with more than 1,4 million of cases reported since 1977. Long-term history of the registry allows even 30-yrs relative survival estimates with mortality data separating death events due to cancer from the other reasons. Finally, summed numbers of patents that are probable to be treated in a given year are supported with reasonable confidence limits. All estimates are performed in age-specific format with respect to the clinical stage of the patients.
PrintDisplayed: 1/10/2024 00:08